NovoCure Ltd (NASDAQ: NVCR): Is It A Buying Opportunity Again?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

NVCR belongs to the Healthcare sector of the NASDAQ while operating in the Medical Devices industry. The current market capitalization of NovoCure Ltd is $1.95B. A total of 0.52 million shares were traded on the day, compared to an average of 1.39M shares.

In the most recent transaction, Cordova Ashley sold 688 shares of NVCR for 20.14 per share on Aug 02 ’24. After the transaction, the Chief Financial Officer now owns 219,179 company shares. In a previous transaction on Jun 04 ’24, VERNON W ANTHONY sold 964 shares at 23.89 per share. NVCR shares that Director owns now total 164,833.

Among the insiders who sold shares, Scannell Timothy J disposed of 964 shares on Jun 04 ’24 at a per-share price of $23.89. This resulted in the Director holding 2,964 shares of NVCR after the transaction. In another insider transaction, LEUNG GABRIEL sold 964 shares at $23.89 per share on Jun 04 ’24. Company shares held by the Director now total 78,175.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, NVCR has a high of $24.74 and a low of $10.87.

As of this writing, NVCR has an earnings estimate of -$0.33 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.23 per share and a lower estimate of -$0.41. The company reported an EPS of -$0.46 in the last quarter

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. NVCR’s latest balance sheet shows that the firm has $937.70M in Cash & Short Term Investments as of fiscal 2021. There were $575.21M in debt and $142.60M in liabilities at the time. Its Book Value Per Share was $3.35, while its Total Shareholder’s Equity was $410.49M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NVCR is Buy with a score of 3.86.

Most Popular

Related Posts